Kamlesh Gidwani

A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources (2016)

Clinical Chemistry

Gidwani Kamlesh, Huhtinen Kaisa, Kekki Henna, van Vliet Sandra, Hynninen Johanna, Koivuviita Niina, Perheentupa Antti, Poutanen Matti, Auranen Annika, Grenman Seija, Lamminmaki Urpo, Carpen Olli, van Kooyk Yvette, Pettersson Kim

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Strong Association between Serological Status and Probability of Progression to Clinical Visceral Leishmaniasis in Prospective Cohort Studies in India and Nepal (2014)

PLoS Neglected Tropical Diseases

Epco Hasker, Paritosh Malaviya, Kamlesh Gidwani, Albert Picado, Bart Ostyn, Sangeeta Kansal, Rudra Pratap Singh, Om Prakash Singh, Ankita Chourasia, Abhishek Kumar Singh, Ravi Shankar, Mary E. Wilson, Basudha Khanal, Suman Rijal, Marleen Boelaert, Shyam Sundar

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Leishmania Specific CD4 T Cells Release IFN gamma That Limits Parasite Replication in Patients with Visceral Leishmaniasis (2014)

PLoS Neglected Tropical Diseases

Rajiv Kumar, Neetu Singh, Shalini Gautam, Om Prakash Singh, Kamlesh Gidwani, Madhukar Rai, David Sacks, Shyam Sundar, Susanne Nylén

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Ota yhteyttä

Julkaisut

Järjestä:

A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources (2016)

Strong Association between Serological Status and Probability of Progression to Clinical Visceral Leishmaniasis in Prospective Cohort Studies in India and Nepal (2014)

Leishmania Specific CD4 T Cells Release IFN gamma That Limits Parasite Replication in Patients with Visceral Leishmaniasis (2014)